Preparation & in vitro evaluation of (90)Y-DOTA-rituximab

BACKGROUND & OBJECTIVES: Radioimmunotherapy is extensively being used for the treatment of non-Hodgkin's lymphoma (NHL). Use of rituximab, a chimeric anti-CD20 antibody directed against the CD20 antigen in combination with suitable beta emitters is expected to result in good treatment respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameswaran, Mythili, Pandey, Usha, Dash, Ashutosh, Samuel, Grace, Venkatesh, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822370/
https://www.ncbi.nlm.nih.gov/pubmed/26997015
http://dx.doi.org/10.4103/0971-5916.178593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822370/
https://www.ncbi.nlm.nih.gov/pubmed/26997015
http://dx.doi.org/10.4103/0971-5916.178593

Ejemplares similares